Overview

Treatment of Multiple Attacks of Acute Migraine (0462-025)

Status:
Completed
Trial end date:
1996-04-01
Target enrollment:
Participant gender:
Summary
A study to evaluate rizatriptan for the treatment of multiple attacks of acute migraine compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Rizatriptan